Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 1, 2008
Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatmentJ Subiza, A Feliú, J L Subiza, et al.
Biochemical Pharmacology|September 2, 2018
Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosisL Mestre, F J Carrillo-Salinas, M Mecha, et al.
Pharmacology & Therapeutics|July 5, 2016
Microglia activation states and cannabinoid system: Therapeutic implicationsM Mecha, F J Carrillo-Salinas, A Feliú, et al.
Anales Espanoles De Pediatria|November 1, 1991
[Prediction of physical endurance in athletes during puberty: analysis of high performance soccer players]A Feliú Rovira, M Albanell Pemán, C Bestit Cartasona, et al.
Brain, Behavior, and Immunity|December 25, 2018
The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microgliaM Mecha, N Yanguas-Casás, A Feliú, et al.
British Journal of Pharmacology|April 11, 2015
A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosisA Feliú, M Moreno-Martet, M Mecha, et al.
Brain, Behavior, and Immunity|June 19, 2015
Endocannabinoids drive the acquisition of an alternative phenotype in microgliaM Mecha, A Feliú, F J Carrillo-Salinas, et al.
Scientific Reports|March 15, 2017
Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virusF J Carrillo-Salinas, L Mestre, M Mecha, et al.
Pageof 1